Literature DB >> 24720427

A retrospective review of the therapeutic response with remission in patients with newly diagnosed bullous pemphigoid.

Sai Yee Chuah1, Suat Hoon Tan, Sze Hon Chua, Mark B Y Tang, Yen Loo Lim, Ching Yin Neoh, Audrey W H Tan.   

Abstract

We reviewed the clinical characteristics and therapeutic response in cases of newly diagnosed bullous pemphigoid at the National Skin Centre between June 2009 and December 2010. Most (76%, n = 68/90) achieved clinical remission within 6 months of commencement of therapy. Oral mucosal involvement was identified as a risk factor associated with a prolonged duration of treatment beyond 6 months.
© 2014 The Authors. Australasian Journal of Dermatology © 2014 The Australasian College of Dermatologists.

Entities:  

Keywords:  autoimmune disease; bullous pemphigoid; remission; therapeutic response

Mesh：

Substances：

Year:  2014        PMID： 24720427     DOI： 10.1111/ajd.12040

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


  3 in total

1.  Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.

Authors:  Marina Alexandre; Gérôme Bohelay; Thomas Gille; Christelle Le Roux-Villet; Isaac Soued; Florence Morin; Frédéric Caux; Sabine Grootenboer-Mignot; Catherine Prost-Squarcioni
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

Review 2.  Desquamative Gingivitis in the Context of Autoimmune Bullous Dermatoses and Lichen Planus-Challenges in the Diagnosis and Treatment.

Authors:  Ana Maria Sciuca; Mihaela Paula Toader; Carmen Gabriela Stelea; George Alexandru Maftei; Oana Elena Ciurcanu; Ovidiu Mihail Stefanescu; Bianca-Andreea Onofrei; Cristina Popa
Journal:  Diagnostics (Basel)       Date:  2022-07-20

Review 3.  Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review.

Authors:  Xinyi Chen; Wenlin Zhao; Hongzhong Jin; Li Li
Journal:  Front Med (Lausanne)       Date:  2021-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.